University of Patras
Μελέτη υλικών βιολογικού ενδιαφέροντος μέσω προηγμένων φασματοσκοπικών τεχνικών
Abstract
dc:descriptionRecently the study of biomaterials has moved in two directions, the evolution of drug deliverysystems and of systems that can stimulate specific cellular responses. Our investigation aims tothe study of drug delivery systems for bone cancer therapy. These systems must fulfill twoimportant functionalities. At first, they should be able to deliver drug molecules to bone cancerenvironment through loading or surface conjugation and subsequently to cause osteogenesis.Their second functionality is especially important since it leads to substitution of bone defectscaused from the action of cancer cells. Bioactive glasses are of great advantage because of theirability to form hydroxyapatite and to bond to bone tissue after implantation. However,compared to bioglasses, bioactive nanospheres offer quite interesting advantages due to theirenhanced properties in drug delivery and their ability to seal bone defects of irregulargeometry.For this purpose in the present thesis characteristic bioactive glassy structures are studied inorder to investigate their conversion to nanoscale structures for further application in drugdelivery as target agents in bone cancer. Of great importance is the investigation of the role ofphosphorus in osteogenesis. Therefore, the ex vitro study of local phosphorous environment in45S5 bioglasses is studied through 31P MAS NMR and 1H-31P CP MAS NMR experiments.The nearly identical NMR spectra obtained by cross-polarization verified that the 31Penvironments and its SBF induced surface layers consist of water molecules and OH groupswhich are probably primarily associated with the a-CaP surface layer and secondly with theCaP components of the bioglasses. Moreover, the confirmed presence of a-CaP surface layerwas observed through the full width at half-maximum height which is significantly broaderthan that presented by nano-crystalline HCA and is typical for an amorphous orthophosphatephase. The obtained information proved the important contribution of the phosphorousenvironment from the first stage of apatite formation, the presence of which results inenhanced contribution to HCA formation and subsequent osteogenesis.Furthermore, the ability of the glassy network to deliver drug molecules was studied. For thispurpose, expanded ex vitro research was followed in DOX conjugated pH-sensitivefunctionalized silica xerogels. Specifically, silica xerogels were synthesized through a sol-gelprocess and further functionalized with carbodiimide chemistry. The functionalization processresulted in pH-sensitive dextran hydrogels. The anticancer drug DOX was bounded on thefunctionalized xerogel by a second stage of EDC coupling. Moreover the bioactivities of thefunctionalized xerogels in connection to release studies in acidic and neutral pH were alsofollowed. According to the SBF study, flake-like apatite formations were observed after 7 daysof treatment. The release of the DOX through an acidic treatment can possibly be attributed toan acidic sensitive esteric bond formation. Consequently, the above organically modified xerogels can probably act in targeted bone cancer therapy, where drug release and boneregeneration are expected.The study of the enhanced properties of glassy substrates was followed by the synthesis ofamorphous bioactive nanospheres. The compositions studied are binary silicate SiO2 - CaO,SiO2 - MgO, SiO2 - Na2O, triple SiO2–CaO-Na2O, SiO2 - P2O5 - CaO, SiO2-P2O5-Na2O andternary SiO2-P2O5-CaO-Na2O. For the synthesis of the glassy hollow nanospheres the sol-gelmethod was used, with polystyrene core nanoparticles resulting in silicate and phosphosilicatenanospheres. In order to investigate the coating process different coating parameters werestudied such as H2O:EtOH proportion, the concentration of initiators as well as the substrate’sconcentration. Moreover, the removal of the polystyrene core was studied by treatment inwater/THF solution, which resulted in 30% core removal. Due to the remnant PS core aftertreatment in water/THF solution, the change of the organic core and the use of PMMA-coHPMAwere advantageous due to the enhanced mechanical properties of PMMA-co-HPMAand its use in bone cements. The use of PMMA-co-HPMA nanoparticles results in phaseseparation of TEOS which occurs in the interphase of PMMA-co-HPMA. Specifically, the areaof surface polymerization constitutes the nucleation sites where the polycondensation of themonomer occurs and results to the stabilization of the glassy network. After the coatingprocess the hybrid nanospheres present smaller diameter than the template PMMA-co-HPMAnanoparticles. Next, the functionalization of PMMA-co-HPMA/SiO2 nanospheres wasimplemented in order to enhance the morphology and functionality of the silica network. Themorphology specifies the extent of interface between the drug delivery nanospheres and thesimulated body fluids and may affect the drug release rate. For the reason, the PMMA-coHPMA/SiO2 nanospheres were functionalized with APTES.In order to accomplish our comparative investigation, we followed the ex vitro study of theabove hybrid binary silicate, ternary and quaternary phosphosilicate nanospheres as well as thesilicate PS and PMMA-co-HPMA nanospheres. The incubation in SBF solution resulted in theformation of a silica-substituted carbonate hydroxyapatite (Si-HCA) a with crystallite size ofaround 45 nm and extended surface aggregates. Moreover, the hybrid PS and PMMA-coHPMAnanospheres constitute a distinctive case of silicate systems with no calcium contentwhich present biocompatible properties. They are characterized by the formation of a silicasubstitutedcarbonate hydroxyapatite (Si-HCA) a with crystallite size of around 50 nm andneedle-like morphology. The amino-modified PMMA-co-HPMA/SiO2 - APTES hybridnanospheres present enhanced biocompatible properties with prolonged release ability as drugdelivery systems in acidic as well as physiological pH. The synthesis and functionalization ofhybrid PMMA-co-HPMA / silicate nanospheres results in drug delivery systems for bonecancer targeting
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Angelopoulou, Athina
- Αγγελοπούλου, Αθηνά
Subjects
dc:subject × 16- Βιοενεργές νανοσφαίρες
- Υδρογέλες δεξτράνης
- Δοξορουμπυσίνη
- pH-ευαίσθητη αποδέσμευση
- Ορθοπεδικά μοσχεύματα
- Bioactive nanospheres
- Dextran hydrogels
- Doxorubicin
- pH-sensitive release
- Orthopedic implants
- Επιστήμες Μηχανικού και Τεχνολογία
- Βιοϊατρική Μηχανική
- Νανοτεχνολογία
- Engineering and Technology
- Medical Engineering
- Nano-Technology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31772